FDA Drugs recall ·
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle… recall
- Recall number
- D-0626-2026
- Date
- (initiated June 4, 2026)
- Company / brand
- Annora Pharma Private Limited
Sy. No.261, Plot No. 13 And 14, Annaram Village, Gummadidal Mandal, Hyderabad, N/A, India - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 31,392 60-count bottles
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
Why was it recalled?
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot: A253999, A254000, Expires: 09/30/2027.
Distribution
Nationwide in the USA
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0626-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.